相关实验视频

Updated: Jun 26, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

基于机器学习的模型的开发,以预测切除的侵入性肺腺癌的预后

Jie Huang¹, Jiannan Qian^1,2, Yunshan Zhong³

¹Department of Thoracic Oncology, Hangzhou Cancer Hospital, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China.

Journal of thoracic disease

|January 12, 2026

概括

这项研究开发了一种机器学习模型,用于预测侵袭性肺腺癌患者的无疾病生存率,为早期干预和改善结果提供了一种工具.

科学领域:

在瘤学瘤学.
医疗信息学医疗信息学
机器学习机器学习

背景情况:

侵入性肺腺癌 (IPA) 是一个主要的全球健康问题.
瘤复发和转移仍然是IPA患者面临的重大挑战.
准确的预后模型对于有效的患者管理至关重要.

研究的目的:

开发一种优化的机器学习模型,用于预测IPA患者的无病生存期 (DFS).
确定影响IPA中的DFS的关键因素.
为临床医生提供早期医疗干预的工具.

主要方法:

分析了一组670名切除IPA患者的队列.
收集了临床病理学数据和患者结局.
评估了四种机器学习模型,包括使用5倍交叉验证的拉索模型.
用AUC,C指数,校准曲线和DCA.来评估模型性能.

主要成果:

拉索模型在预测2至5年的DFS方面表现出卓越的表现.
拉索模型在训练和测试组中都获得了高AUC值 (例如,5年AUC:0.927训练,0.887测试).
校准曲线和DCA证实了该模型的良好预测准确性.

结论:

成功构建了一个基于机器学习的IPA DFS强大的预测模型.
这种模型可以作为瘤学家的有效工具.
该模型有可能改善早期医疗干预和患者存活率.

关键词:

国际肺癌研究协会 (IASLC) 是国际肺癌研究协会.侵袭性肺腺癌侵袭性肺腺癌分级系统分级系统分级系统.机器学习是机器学习.预测模型的预测模型.

更多相关视频

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...